Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
about
Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.Radiolabeled cyclosaligenyl monophosphates of 5-iodo-2'-deoxyuridine, 5-iodo-3'-fluoro-2',3'-dideoxyuridine, and 3'-fluorothymidine for molecular radiotherapy of cancer: synthesis and biological evaluationSpontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies.Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters
P2860
Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Preclinical evaluation of loco ...... inhibitor in a hepatoma model.
@ast
Preclinical evaluation of loco ...... inhibitor in a hepatoma model.
@en
type
label
Preclinical evaluation of loco ...... inhibitor in a hepatoma model.
@ast
Preclinical evaluation of loco ...... inhibitor in a hepatoma model.
@en
prefLabel
Preclinical evaluation of loco ...... inhibitor in a hepatoma model.
@ast
Preclinical evaluation of loco ...... inhibitor in a hepatoma model.
@en
P2093
P1476
Preclinical evaluation of loco ...... inhibitor in a hepatoma model.
@en
P2093
P304
P407
P577
2001-02-01T00:00:00Z